Thiazol-2-Ylidene Coordination to CYP3A4
51
Grimme S, Ehrlich S, and Goerigk L (2011) Effect of the damping function in dis-
persion corrected density functional theory. J Comput Chem 32:1456–1465.
Guengerich FP (2001) Uncommon P450-catalyzed reactions. Curr Drug Metab 2:
Neese F (2012) The ORCA program system. WIRES: Comp Mol Sci 2:73–78.
Neese F, Wennmohs F, Hansen A, and Becker U (2009) Efficient, approximate and
parallel Hartree–Fock and hybrid DFT calculations. A ‘chain-of-spheres’ algorithm
for the Hartree–Fock exchange. Chem Phys 356:98–109.
9
3–115.
Henry ER and Hofrichter J (1992) Singular value decomposition: application to
Ortiz de Montellano PR (2005) Cytochrome P450: structure, mechanism, and bio-
chemistry, 3rd ed, Kluwer Academic/Plenum, New York.
Podstawka E, Mak PJ, Kincaid JR, and Proniewicz LM (2006) Low frequency reso-
nance Raman spectra of isolated alpha and beta subunits of hemoglobin and their
deuterated analogues. Biopolymers 83:455–466.
Rendic S (2002) Summary of information on human CYP enzymes: human P450
metabolism data. Drug Metab Rev 34:83–448.
Ring BJ, Patterson BE, Mitchell MI, Vandenbranden M, Gillespie J, Bedding AW,
Jewell H, Payne CD, Forgue ST, and Eckstein J et al. (2005) Effect of tadalafil on
cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo. Clin
Pharmacol Ther 77:63–75.
Ruf HH, Ahr H, Nastainczyk W, Ullrich V, Mansuy D, Battioni JP, Montiel-Montoya
R, and Trautwein A (1984) Formation of a ferric carbanion complex from halothane
and cytochrome P-450: electron spin resonance, electronic spectra, and model
complexes. Biochemistry 23:5300–5306.
Sevrioukova IF and Poulos TL (2010) Structure and mechanism of the complex be-
tween cytochrome P4503A4 and ritonavir. Proc Natl Acad Sci USA 107:
18422–18427.
Heydari A, Yeo KR, Lennard MS, Ellis SW, Tucker GT, and Rostami-Hodjegan A
2004) Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphet-
(
amine. Drug Metab Dispos 32:1213–1217.
Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM,
Johnson VA, Kuritzkes DR, Mellors JW, and Pillay D et al.; International AIDS
Society-USA (2008) Antiretroviral drug resistance testing in adult HIV-1 infection:
2
1
008 recommendations of an International AIDS Society-USA panel. Top HIV Med
6:266–285.
Hodgson E and Philpot RM (1974) Interaction of methylenedioxyphenyl (1,3-benzo-
dioxole) compounds with enzymes and their effects on mammals. Drug Metab Rev
3:231–301.
Hollenberg PF (2002) Characteristics and common properties of inhibitors, inducers,
and activators of CYP enzymes. Drug Metab Rev 34:17–35.
Hopmann RF and Brugnoni GP (1973) pK of thiamine C(2)H. Nat New Biol 246:
1
57–158.
Jordan F, Li H, and Brown A (1999) Remarkable stabilization of zwitterionic inter-
mediates may account for a billion-fold rate acceleration by thiamin diphosphate-
dependent decarboxylases. Biochemistry 38:6369–6373.
Kaur P, Chamberlin R, Poulos TL, and Sevrioukova IF (2015) Structure-based in-
Kempf DJ, Marsh KC, Denissen JF, McDonald E, Vasavanonda S, Flentge CA, Green
BE, Fino L, Park CH, and Kong XP et al. (1995) ABT-538 is a potent inhibitor of
human immunodeficiency virus protease and has high oral bioavailability in hu-
mans. Proc Natl Acad Sci USA 92:2484–2488.
Sevrioukova IF and Poulos TL (2012) Interaction of human cytochrome P4503A4
with ritonavir analogs. Arch Biochem Biophys 520:108–116.
Sevrioukova IF and Poulos TL (2013) Dissecting cytochrome P450 3A4-ligand in-
teractions using ritonavir analogues. Biochemistry 52:4474–4481.
Shaik S, Cohen S, Wang Y, Chen H, Kumar D, and Thiel W (2010) P450 enzymes:
their structure, reactivity, and selectivity-modeled by QM/MM calculations. Chem
Rev 110:949–1017.
Shaik S, Kumar D, de Visser SP, Altun A, and Thiel W (2005) Theoretical perspective
on the structure and mechanism of cytochrome P450 enzymes. Chem Rev 105:
2279–2328.
Kempf DJ, Marsh KC, Kumar G, Rodrigues AD, Denissen JF, McDonald E, Kukulka
MJ, Hsu A, Granneman GR, and Baroldi PA et al. (1997) Pharmacokinetic en-
hancement of inhibitors of the human immunodeficiency virus protease by co-
administration with ritonavir. Antimicrob Agents Chemother 41:654–660.
Kena Diba A, Noll C, Richter M, Gieseler MT, and Kalesse M (2010) Intramolecular
stereoselective protonation of aldehyde-derived enolates. Angew Chem Int Ed Engl
Sugimoto H, Shinkyo R, Hayashi K, Yoneda S, Yamada M, Kamakura M,
Ikushiro S, Shiro Y, and Sakaki T (2008) Crystal structure of CYP105A1
(P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3. Biochemistry 47:
4017–4027.
Swart M, Güell M, Luis JM, and Solà M (2010) Spin-state-corrected Gaussian-type
orbital basis sets. J Phys Chem A 114:7191–7197.
Tao J, Perdew JP, Staroverov VN, and Scuseria GE (2003) Climbing the density
functional ladder: nonempirical meta-generalized gradient approximation
designed for molecules and solids. Phys Rev Lett 91:146401.
Verras A, Alian A, and de Montellano PR (2006) Cytochrome P450 active site plas-
ticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A
mutation. Protein Eng Des Sel 19:491–496.
von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Duan SX, Fogelman SM,
Daily JP, Harmatz JS, and Shader RI (1998) Protease inhibitors as inhibitors of
human cytochromes P450: high risk associated with ritonavir. J Clin Pharmacol
38:106–111.
Weigend F and Ahlrichs R (2005) Balanced basis sets of split valence, triple zeta
valence and quadruple zeta valence quality for H to Rn: design and assessment of
accuracy. Phys Chem Chem Phys 7:3297–3305.
Wolf CR, Mansuy D, Nastainczyk W, Deutschmann G, and Ullrich V (1977) The
reduction of polyhalogenated methanes by liver microsomal cytochrome P450. Mol
Pharmacol 13:698–705.
Zhao Y and Truhlar DG (2008) Density functionals with broad applicability in chem-
istry. Acc Chem Res 41:157–167.
4
9:8367–8369.
Kern D, Kern G, Neef H, Tittmann K, Killenberg-Jabs M, Wikner C, Schneider G,
and Hübner G (1997) How thiamine diphosphate is activated in enzymes. Science
2
75:67–70.
Klibanov OM, Gale SE, and Santevecchi B (2015) Ombitasvir/paritaprevir/ritonavir
and dasabuvir tablets for hepatitis C virus genotype 1 infection. Ann Pharmacother
4
9:566–581.
Koudriakova T, Iatsimirskaia E, Utkin I, Gangl E, Vouros P, Storozhuk E, Orza D,
Marinina J, and Gerber N (1998) Metabolism of the human immunodeficiency
virus protease inhibitors indinavir and ritonavir by human intestinal microsomes
and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cyto-
chrome P4503A by ritonavir. Drug Metab Dispos 26:552–561.
Lin HL, Kent UM, and Hollenberg PF (2002) Mechanism-based inactivation of cy-
tochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction
and covalent binding to protein. J Pharmacol Exp Ther 301:160–167.
Mak PJ, Podstawka E, Kincaid JR, and Proniewicz LM (2004) Effects of systematic
peripheral group deuteration on the low-frequency resonance Raman spectra of
myoglobin derivatives. Biopolymers 75:217–228.
Mak PJ, Zhu Q, and Kincaid JR (2013) Using resonance Raman cross-section data to
estimate the spin state populations of cytochromes P450. J Raman Spectrosc 44:
1
792–1794.
Address correspondence to: John C Hackett, Department of Physiology and
Biophysics and the Massey Cancer Center, Virginia Commonwealth Univer-
Mansuy D, Battioni JP, Chottard JC, and Ullrich
V
(1979) Preparation of a
porphyrin-iron-carbene model for the cytochrome P 450 complexes obtained upon
metabolic oxidation of the insecticide synergists of the 1,3-benzodioxole series.
J Am Chem Soc 101:3971–3973.